|
| 1 |
Cost-Effectiveness Analysis of Three Diagnostic Strategies for the Detection of EGFR Mutation in Advanced Non-Small Cell Lung Cancer
Sun Mi Cho, Hye Sun Lee, Soyoung Jeon, Yoonjung Kim, Sun-Young Kong, Jin Kyung Lee, Kyung-A Lee
Ann Lab Med.2023;43(6):605-613. Published online 2023 June 30
DOI: http://dx.doi.org/10.3343/alm.2023.43.6.605
|
|
| 2 |
EGFR-TKI Combined with Pemetrexed versus EGFR-TKI Monotherapy in Advanced EGFR-Mutated NSCLC: A Prospective, Randomized, Exploratory Study
Weiguang Gu, Hua Zhang, Yiyu Lu, Minjing Li, Shuang Yang, Jianmiao Liang, Zhijian Ye, Zhihua Li, Minhong He, Xiaoliang Shi, Fei Wang, Dong You, Weiquan Gu, Weineng Feng
Cancer Res Treat.2023;55(3):841-850. Published online 2023 February 13
DOI: http://dx.doi.org/10.4143/crt.2022.1438
|
|
| 3 |
Effect of Afatinib for Lung Cancer on Papillary Thyroid Carcinoma
Sang Hwon Cho, Jin Seok Lee, Hyeok Jun Yun, Yong Sang Lee, Hang-Seok Chang
|
|
| 4 |
EGFR Mutation–Positive Unresectable Stage III Non-Squamous Lung Cancer Is Associated with a High Incidence of Brain Metastasis
Hongsik Kim, Sehhoon Park, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn
Cancer Res Treat.2023;55(2):498-505. Published online 2022 October 4
DOI: http://dx.doi.org/10.4143/crt.2022.388
|
|
| 5 |
Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation–Positive Non–Small Cell Lung Cancer
Jang Ho Lee, Eun Young Kim, Cheol-Kyu Park, Shin Yup Lee, Min Ki Lee, Seong-Hoon Yoon, Jeong Eun Lee, Sang Hoon Lee, Seung Joon Kim, Sung Yong Lee, Jun Hyeok Lim, Tae-Won Jang, Seung Hun Jang, Kye Young Lee, Seung Hyeun Lee, Sei Hoon Yang, Dong Won Park, Chan Kwon Park, Hye Seon Kang, Chang Dong Yeo, Chang-Min Choi, Jae Cheol Lee
Cancer Res Treat.2023;55(1):112-122. Published online 2022 July 19
DOI: http://dx.doi.org/10.4143/crt.2022.381
|
|
| 6 |
Osimertinib Combined with Systemic Chemotherapy for EGFR Mutant, T790M-Negative, Non–Small Cell Lung Cancer Patients Who Develop Leptomeningeal Metastases with Extracranial Progression to Prior EGFR TKI
Hye Ryeon Kim, Hyunji Jo, Hongsik Kim, Joohyun Hong, Sehhoon Park, Hyun Ae Jung, Se-Hoon Lee, Jin-Seok Ahn, Myung-Ju Ahn
Cancer Res Treat.2023;55(1):344-349. Published online 2022 March 26
DOI: http://dx.doi.org/10.4143/crt.2021.1603
|
|
| 7 |
The Impact of EGFR Tyrosine Kinase Inhibitor on the Natural Course of Concurrent Subsolid Nodules in Patients with Non–Small Cell Lung Cancer
Noeul Kang, Ki Hwan Kim, Byeong-Ho Jeong, Kyungjong Lee, Hojoong Kim, O Jung Kwon, Myung-Ju Ahn, Jeonghee Cho, Ho Yun Lee, Sang-Won Um
Cancer Res Treat.2022;54(3):817-826. Published online 2021 November 9
DOI: http://dx.doi.org/10.4143/crt.2021.822
|
|
| 8 |
Correlation of TTF-1 immunoexpression and EGFR mutation spectrum in non–small cell lung carcinoma
Tripti Nakra, Varsha Singh, Aruna Nambirajan, Prabhat Singh Malik, Anant Mohan, Deepali Jain
|
|
| 9 |
Acquired Resistance Mechanism of EGFR Kinase Domain Duplication to EGFR TKIs in Non–Small Cell Lung Cancer
Chaelin Lee, Miso Kim, Dong-Wan Kim, Tae Min Kim, Soyeon Kim, Sun-Wha Im, Yoon Kyung Jeon, Bhumsuk Keam, Ja-Lok Ku, Dae Seog Heo
|
|
| 10 |
Liquid biopsy using extracellular vesicle–derived DNA in lung adenocarcinoma
In Ae Kim, Jae Young Hur, Hee Joung Kim, Seung Eun Lee, Wan Seop Kim, Kye Young Lee
|
|
| 11 |
A Phase II Trial of Osimertinib as the First-Line Treatment of Non–Small Cell Lung Cancer Harboring Activating EGFR Mutations in Circulating Tumor DNA: LiquidLung-O-Cohort 1
Cheol-Kyu Park, Hyun-Ju Cho, Yoo-Duk Choi, In-Jae Oh, Young-Chul Kim
Cancer Res Treat.2021;53(1):93-103. Published online 2020 September 21
DOI: http://dx.doi.org/10.4143/crt.2020.459
|
|
| 12 |
A Meta-Analysis on the Performance of Cystatin C- versus Creatinine-based eGFR Equations in Predicting Vancomycin Clearance
Nor Asyikin Mohd Tahir, Shamin Mohd Saffian, Farida Hanim Islahudin, Abdul Halim Abdul Gafor, Mohd Makmor-Bakry
|
|
| 13 |
EGFR C797S as a Resistance Mechanism of Lazertinib in Non-small Cell Lung Cancer with EGFR T790M Mutation
Sehhoon Park, Bo Mi Ku, Hyun Ae Jung, Jong-Mu Sun, Jin Seok Ahn, Se-Hoon Lee, Keunchil Park, Myung-Ju Ahn
Cancer Res Treat.2020;52(4):1288-1290. Published online 2020 June 22
DOI: http://dx.doi.org/10.4143/crt.2020.278
|
|
| 14 |
Baseline High Blood Pressure is Associated with Clinico-Pathologic Findings and Later Renal Progression in Chronic Glomerulonephritis
Ji Yung Lee, Hyung-Seok Ihm, Jin Sug Kim, Hyeon Seok Hwang, Kyung Hwan Jeong, Chun-Gyoo Ihm
|
|
| 15 |
Correlation of PD-L1 Expression Tested by 22C3 and SP263 in Non-Small Cell Lung Cancer and Its Prognostic Effect on EGFR Mutation–Positive Lung Adenocarcinoma
Taehee Kim, Yoon Jin Cha, Yoon Soo Chang
|
|
| 16 |
Real-World Analysis of the Efficacy of Rebiopsy and EGFR Mutation Test of Tissue and Plasma Samples in Drug-Resistant Non-Small Cell Lung Cancer
Min Hee Hong, Hye Ryun Kim, Beung-Chul Ahn, Su Jin Heo, Jee Hung Kim, Byoung Chul Cho
|
|
| 17 |
Comparison of cobas EGFR Mutation Test v2 and PANAMutyper-R-EGFR for Detection and Semi-Quantification of Epidermal Growth Factor Receptor Mutations in Plasma and Pleural Effusion Supernatant
A-Lum Han, Hak-Ryul Kim, Keum-Ha Choi, Ki-Eun Hwang, Mengyu Zhu, Yuya Huang, Moxin Wu, Young-Jin Lee, Min-Cheol Park, Ji-Hyun Cho, Do-Sim Park
Ann Lab Med.2019;39(5):478-487. Published online 2019 April 26
DOI: http://dx.doi.org/10.3343/alm.2019.39.5.478
|
|
| 18 |
Effects of Pre-analytical Variables on Cell-free DNA Extraction for Liquid Biopsy
Tae-Dong Jeong, Mi Hwa Kim, Sholhui Park, Hae-Sun Chung, Jin Wha Lee, Jung Hyun Chang, Jungwon Huh
|
|
| 19 |
The expression and tyrosine phosphorylation of E-cadherin, beta-, gamma-catenin and EGFR after treatment of EGF and TGF-alpha in Cervical Cancer Cell Lines
Hye Sung Moon, Eun Ah Choi, Hye Young Park
|
|
| 20 |
In Situ Hybridization of EGFR mRNA in Normal, Dysplasic, Carcinoma In Situ and Malignant Cervical Tissues
TE Kim, HK Kim, JS Park, JW Kim, JH Kang, AH Lee, JH Kim, SE Namkoong
|
|
